Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
出版年份 2021 全文链接
标题
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
作者
关键词
-
出版物
DIABETOLOGIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-28
DOI
10.1007/s00125-021-05458-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
- (2021) Sang Youl Rhee et al. Diabetes & Metabolism Journal
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
- (2020) Qiao Shi et al. DIABETES CARE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
- (2020) Xintao Li et al. HEART
- Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
- (2020) Omar Yaxmehen Bello-Chavolla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies
- (2020) Alessandro Mantovani et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
- (2020) Mohammad Parohan et al. Aging Male
- Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia
- (2020) Jia Li et al. AMERICAN JOURNAL OF INFECTION CONTROL
- The Relationship between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China
- (2020) Jian Shang et al. AMERICAN JOURNAL OF MEDICINE
- Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
- (2020) Luxiang Shang et al. ARCHIVES OF MEDICAL RESEARCH
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
- (2020) Shivani Agarwal et al. DIABETES CARE
- Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis
- (2020) Li Guo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study
- (2020) Yumin Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
- (2020) Sufei Wang et al. DIABETOLOGIA
- Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
- (2020) Yue Zhou et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients
- (2020) Priyank Shah et al. JOURNAL OF HYPERTENSION
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis
- (2020) Mária Földi et al. Obesity Reviews
- Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease
- (2020) Hadith Rastad et al. Diabetology & Metabolic Syndrome
- The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID ‐19
- (2020) Zihui Xu et al. Journal of Diabetes
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
- (2020) Rinkoo Dalan et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
- (2020) Jacqueline Seiglie et al. DIABETES CARE
- Haemoglobin A1c is a predictor of COVID‐19 severity in patients with diabetes
- (2020) Eugene Merzon et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis
- (2020) Diana C. Sanchez-Ramirez et al. RESPIRATORY MEDICINE
- Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
- (2020) Stuart J McGurnaghan et al. Lancet Diabetes & Endocrinology
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
- (2019) Oana P Zaharia et al. Lancet Diabetes & Endocrinology
- GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
- (2018) Holger J. Schünemann et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
- (2014) Joanna IntHout et al. BMC Medical Research Methodology
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started